15 episodes

Capturing conversations between AAM leadership and members, thought leaders, legislators and others about topics that intersect the generics and biosimilars space.

AAM All Access AAM All Access

    • Business
    • 5.0 • 2 Ratings

Capturing conversations between AAM leadership and members, thought leaders, legislators and others about topics that intersect the generics and biosimilars space.

    • video
    AAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel Goode

    AAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel Goode

    Today on All Access we discuss Build Back Better and its Impact on the Generic and Biosimilar Industry. My guests are Kurt Karst, Director at Hyman Phelps & McNamara, Rachel Turow, Associate General Counsel for Regulatory Law and Policy and the Head of U.S. Regulatory Policy at Teva Pharmaceuticals, and Rachel Goode, Senior Vice President for Biosimilars Patents and Legal at Fresenius Kabi.  

    • 25 min
    • video
    AAM All Access - Mary Beth Powers of CMMB

    AAM All Access - Mary Beth Powers of CMMB

    Today we talk with CMMB president and chief executive officer, Mary Beth Powers. With a distinct focus on women and children's health all around the world, CMMB and its global network of volunteers deliver long-term care and medicines to communities in Africa, Latin America, the Caribbean and other regions affected by poverty, and who have unequal access to healthcare. The team at CMMB is helping countless thousands of people around the world turn their personal tragedies into triumphs. 

    • 18 min
    • video
    AAM All Access - Managing Drug Shortages

    AAM All Access - Managing Drug Shortages

    Shortages of health care products, like the current baby formula situation, and consumer goods continue to bedevil the U.S. Yet, prescription medicines generally have been available with few disruptions since the start of the pandemic. How are drug shortages kept in check… and just what is a drug shortage, for that matter? Learn the facts by joining AAM CEO Dan Leonard as he speaks to eminent 3 pharmacists, each with different insights into management and mitigation of drug shortages: David Gaugh, SVP, Sciences & Regulatory Affairs, AAM, Jessica Daley, Group VP, Chief Pharmacy Officer, Premier, and Steven Schondelmeyer, professor of pharmacy at the University of Minnesota.

    • 38 min
    • video
    AAM All Access - Thomas Tighe

    AAM All Access - Thomas Tighe

    Direct Relief President and CEO Thomas Tighe joins CEO Dan Leonard to talk about the humanitarian support Direct Relief is providing at the request of Ukraine’s Ministry of Health in the war-torn country and to millions of its refugees in border countries. “We're so thankful for the [generic industry’s] responsiveness. They don't have to do this, it's not their job. That they did it means a lot. It means a lot for people in Ukraine.”

    • 28 min
    • video
    AAM All Access - Alok Sonig

    AAM All Access - Alok Sonig

    Today we're here in Orlando, Florida during our Annual Meeting, ACCESS! We're talking with Alok Sonig, CEO, US Generics, and Head of Global R&D & Biosimilars at Lupin Incorporated.

    • 19 min
    • video
    AAM All Access - Kendra Davenport

    AAM All Access - Kendra Davenport

    Our guest today is Kendra Davenport, the chief development officer for Operation Smile. Operation Smile is one of the largest volunteer surgical nonprofits in the world and an AAM member company. The team does far more than just change a child's smile, it truly transforms their life. 

    • 20 min

Customer Reviews

5.0 out of 5
2 Ratings

2 Ratings

Top Podcasts In Business

Ramsey Network
NPR
iHeartPodcasts
Vox Media Podcast Network
Guy Raz | Wondery
Jocko DEFCOR Network

You Might Also Like